Found: 185
Select item for more details and to access through your institution.
A 20-year multicentre retrospective review of optic nerve sheath fenestration outcomes.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231197994
- By:
- Publication type:
- Article
Network topology in brain tumor patients with and without structural epilepsy: a prospective MEG study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231190298
- By:
- Publication type:
- Article
Risk factors for super-refractory and mortality in generalized convulsive status epilepticus: a 10-year retrospective cohort study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231214846
- By:
- Publication type:
- Article
Objectivity, practicality, and significance of practice guidelines for the practicing neurologists: What we learnt from consensus criteria in CIDP, Myasthenia Gravis and Inflammatory Myopathies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231194821
- By:
- Publication type:
- Article
A novel use and dramatic efficacy of ofatumumab for the treatment of anti-N-methyl-D-aspartate receptor encephalitis: a report of two cases.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231161890
- By:
- Publication type:
- Article
Guideline for the management of myasthenic syndromes.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231213240
- By:
- Publication type:
- Article
Late-onset stiff-person syndrome: challenges in diagnosis and management.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231214315
- By:
- Publication type:
- Article
Defining the course of neurosarcoidosis according to presentation at onset and disease modifying treatment: a cohort study of 84 patients.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231205954
- By:
- Publication type:
- Article
The pivotal role of timing of intravenous thrombolysis bridging treatment prior to endovascular thrombectomy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231216637
- By:
- Publication type:
- Article
Clinical characteristics, treatments, and outcomes of interferon-beta-induced thrombotic microangiopathy: a literature-based retrospective analysis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231216634
- By:
- Publication type:
- Article
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231211077
- By:
- Publication type:
- Article
Pregnancy outcomes in female multiple sclerosis patients exposed to intramuscular interferon beta-1a or peginterferon beta-1a reported in a German Patient Support Programme – results from the non-interventional post-authorization safety study PRIMA.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231214041
- By:
- Publication type:
- Article
Multimodal imaging-based diagnostic approach for MRI-negative posterior cortex epilepsy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231212254
- By:
- Publication type:
- Article
A secondary daily persistent headache from onset with underlying nutcracker physiology and spinal epidural venous congestion: case series with lumbar vein embolization as a therapeutic approach.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231213243
- By:
- Publication type:
- Article
The vascular locked-in and locked-in-plus syndrome: A retrospective case series.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231207272
- By:
- Publication type:
- Article
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231200627
- By:
- Publication type:
- Article
Feasibility of home dose optimization of apomorphine sublingual film in Parkinson's disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231209240
- By:
- Publication type:
- Article
Perspective: Industry–patient relationships for the promotion of pharmaceutical agents.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Treatment of acute ischemic stroke in patients with active malignancy: insight from a comprehensive stroke center.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231207508
- By:
- Publication type:
- Article
Optimizing treatment persistence in epilepsy: a comparative analysis of combined antiseizure medications with different mechanisms of action.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231207161
- By:
- Publication type:
- Article
Long-term efficacy and adverse effects of cannabidiol in adjuvant treatment of drug-resistant epilepsy: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231207755
- By:
- Publication type:
- Article
Corneal immune cells as a biomarker of inflammation in multiple sclerosis: a longitudinal study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231204974
- By:
- Publication type:
- Article
The impact of disease-modifying therapies on immunoglobulin blood levels in patients with multiple sclerosis: a retrospective cross-sectional study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231162661
- By:
- Publication type:
- Article
Structural connections of the centromedian nucleus of thalamus and their relevance for neuromodulation in generalized drug-resistant epilepsy: insight from a tractography study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231202064
- By:
- Publication type:
- Article
Epileptic seizures at multiple sclerosis onset and their role in disease progression.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231192826
- By:
- Publication type:
- Article
Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231177196
- By:
- Publication type:
- Article
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231180730
- By:
- Publication type:
- Article
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231198963
- By:
- Publication type:
- Article
A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231195513
- By:
- Publication type:
- Article
Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231194823
- By:
- Publication type:
- Article
Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231193816
- By:
- Publication type:
- Article
Limb myorhythmia treated with chemodenervation: a case report.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864221150317
- By:
- Publication type:
- Article
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231197309
- By:
- Publication type:
- Article
Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231191000
- By:
- Publication type:
- Article
Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal seizures: post hoc analysis of a phase III trial and open-label extension study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231193530
- By:
- Publication type:
- Article
Comment on 'The overlapping relationship among depression, anxiety, and somatic symptom disorder and its impact on the quality of life of people with epilepsy'.
- Published in:
- 2023
- By:
- Publication type:
- Letter
International beliefs and head positioning practices in patients with spontaneous hyperacute intracerebral hemorrhage.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231161162
- By:
- Publication type:
- Article
A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231191590
- By:
- Publication type:
- Article
Impact of the updated chronic inflammatory demyelinating polyneuropathy guideline on everyday clinical practice.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231190549
- By:
- Publication type:
- Article
IgM to phosphatidylcholine in multiple sclerosis patients: from the diagnosis to the treatment.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231189919
- By:
- Publication type:
- Article
Contactin-associated protein 2 autoantibodies can be associated with multifocal motor-like neuropathy: a case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
mTOR pathway – a potential therapeutic target in stroke.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231187770
- By:
- Publication type:
- Article
The effectiveness of teriflunomide in patients with multiple sclerosis in China: a real-world comparison to no DMT treatment in the first year after diagnosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231181170
- By:
- Publication type:
- Article
Therapeutic plasma exchange in the management of stiff person syndrome spectrum disorders: a case series and review of the literature.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231180736
- By:
- Publication type:
- Article
Complete remission of central nervous system manifestations of IgG4-related disease with rituximab – a case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231180734
- By:
- Publication type:
- Article
Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231183221
- By:
- Publication type:
- Article
Cardiac therapies for Duchenne muscular dystrophy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231182934
- By:
- Publication type:
- Article
Long-term safety and effectiveness of eculizumab in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a 2-year interim analysis of post-marketing surveillance in Japan.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231181177
- By:
- Publication type:
- Article
Is the central nervous system enclosed by a mesothel?
- Published in:
- 2023
- By:
- Publication type:
- Letter